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Abstract: In recent years, it has been noted that there is a close correlation between
leukotrienes and late asthmatic reaction (LAR). In this study, effects of dietary
supplementation with perilla seed oil rich in alpha-linolenic acid. which is speculated to
affect the generation of leukotrienes through metabolism of arachidonic acid (AA),
were evaluated in 6 patients with asthma. The symptoms and ventilatory function
were improved after 2 -week dietary supplementation with perilla seed oil. The
generation of LTB 4 and LTC4 by peripheral leucocytes stimulated with Ca ionophore
A23187 was significantly suppressed by the dietary supplementation (LTB4 and
LTC 4 ; p<O.05). Regarding the composition of fatty acids in serum phospholipids, the
concentrations of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and AA
tended to increase after the supplementation, accompanied with an increase in the ratio
of EPA to AA. These results suggest that dietary supplementation with perilla seed oil
brings beneficial effects in the treatment of asthma.
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Introduction
It has been suggested that dietary sup-
plementation with polyunsaturated fatty
acids (PUFA) is beneficial for the treatment
of various chronic diseases. Unsaturated fa-
tty acids of marine origin, such as eicosa-
pentaenoic acid (EPA) and docosahexaenoic
acid (DBA), protect the progress of cardio-
vascular disease 1) by modyfying prostanoid
synthesis 2). In contrst, effects of supple-
mentation with n - 3 fatty acids on bron-
chial asthma are still controversial 3). how-
ever, several reports suggest beneficial effects
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of n - 3 fatty acids on asthma and allergic
rhinitis •-7) •
It has been reported that there is a nega-
tive correlation between linoleic acid (LA)
intake and serum amounts of EPA in the
elderly 8). The ratio of LA to a -linolenic
acid may have important effects on the levels
of the longer chain n - 3 fatty acids, par-
ticularly EPA, in platelet and plasma fatty
acids 9), suggesting the importance of n - 3
/n- 6 fatty acid ratio in serum total
phospholipids.
In the present study, effects of dietrary
supplementation with perilla seed oil on
bronchial asthma were evaluated in relation
to symptoms, ventilatory function, genera-
tion of leukotrienes B4 and C4 by leucocytes,
and changes In composition of serum
phospholipid fatty acids.
Subjects and Methods
The subjects of this study were 6 patients
(5 females and 1 male) with asthma,
including one patient with cough variant
asthma (CVA). Their mean age was 62 years
(range 51-72 years), and the mean of serum
IgE was 178.8 IU/mP (range 7 ~720 IU/mp),
Clinical symptoms and peak flow rate (PFR)
in the early morning and evening were re-
corded in all subjects. Bronchial reactivity
to /3 2 agonist was estimated in all subjects
by observing the improvement of morning
PER after inhalation of salbutamol.
The subjects took 10 - 20 gram of perilla
seed oil per day as salad dressing or
mayonmaise for 2 - 4 weeks. The amount of
oil used in diet and supplementary diet oil
was recorded throughout the study periods.
The generation of leukotrienes B4 (LTB4)
and C 4 (LTC 4) by peripheral leucocuytes
was assessed by a method previously de-
scribed IU II). Cells were separated by coun-
terflow centrifugation elutriation with a JE
6 B rotor (Beckman Co.) 12), as described
previously 13). After the number of the cells
was adjusted to 5 X 106/mP in Tris ACM. Ca
ionophore A23187 (1 11 g) was added to the
cell suspension. The mixed solution was incu-
bated for 15 min at 37° C and centrifuged at
300g for 10 min at 4 ce. The HPLC analysis
for extraction and quantification of LTB 4
and LTC 4 was performed by a method
described by Lam et al. 14). The extraction of
leukotrienes was performed using a C18 Sep-
Pak (Waters Associates). The concentrations
of LTB 4 and LTC 4 were analyzed by HPLC
system, Model 510 (Waters Associates),
equipped with an ultraviolet detector. The
column used was a 5 mm X 10em Radial-Pax
cartridge (Shimazu Co.). The results were
expressed as ng/5 X 10 6 cells.
Analysis of the composition of serum
phospholipid fatty acids was performed by a
method reported by Okita et al. 15) •
Results
The improvement of morning PFR by
inhalation of /3 2 agonist was 47% before
dietary supplementation, and 40% 2 weeks
after the manipulation.
The clinical symptoms tended to improve in
all patients with asthma 2 weeks after
dietary supplementation with perilla seed oil.
The mean peak flow rate (PFR) also im-
proved after the dietary supplementation.
Percent increase in morning PFR before and
after inhalation of /3 2 agonist was 13% and
9% (n= 6), respectively, 2 weeks after the
supplementation (Fig. 1).
Figure 2 shows improvement of PFR in
patient with asthma (56 years old, female)
after the supplementation. The PFR in the
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supple-
medica-
early morning tended to increase 1 week
after the beginning of dietary
mentation. During the periods the
tions were not changed in this case.
The PFR improvement was also observed in
another patient with asthma (58 years old,
female), who received dietary supple-
mentation for 4 weeks. The morning PFR
before and after fJ 2 agonist inhalation
showed a tendency to increase after the
supplementation despite the decrease in dose
of beclomethasone inhalation. Furthermore,
the rate clearly increased after consecutive
dietary supplementation, accompanied with
pranlukast (Fig. 3).
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Ca ionophore A23187-induced generation of
LTB 4 and LTC 4 by peripheral leococytes
was evaluated in 5 patients (including CVA)
before and after manipulation with perilla
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Fig. 1. Improvement of peak flow rate in
asthmatics with dietary supple-
mentation. Data represent the mean
of 6 subjects. Peak flow rate (.-
e) : in the early morning, (0-0) :
after fJ 2 agonist inhalation, and
( ) : in the evening.
110-------
1 2 5 L.-..-'-'--...........................'-'-'---"-'--'-"-'-....l.W.-'-~ .....................
- 2 - 1 0 2 3 (W)
Fig. 2. Changes of peak flow rate in the
early morning (+-+) and after
fJ 2 agonist inhalation ( ) in
asthmatics with dietary supple-
mentation (56 years old, female)
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seed oil. The mean values of LTB 4 and LT
C 4 before the supplementation was 77.6 ±
24.4 and 64.0±33.5ng/5 X 10 6 cells (mean±
3D) respectively. After the oil manipulation
the value of LTB 4 tended to decrease (41.6
± 24.9 ng/ 5 X 10 6 cells) in 4 of the 5
subjects (p<0.05). The decrease of LTB 4
generation was marked in subjects 3, 4,
and 5. whose generation of LTB 4 by
leucocytes was relatively high (Fig. 4).
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Fig. 5. Decreases in the generation of LTC
4 by peripheral leukocytes from
subjects before (D) and after dietary
supplementation (~).
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4. Decreases in the generation of LTB
4 by peripheral leukocytes from
subjects before (D) and after dietary
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The generation of LTC 4 by leucocytes
significantly decreased (38.8 ± 23.2ng/ 5 X
10 6 cells) (p<0.05). Neither peak of LTB 5
and LTC 5 in HPLC was not observed before
and after dietary supplementation (Fig. 5).
The linoleic acid (LA), AA, EPA, and DHA
in plasma phospholipid were 787 ± 103, 327 ±
12, 13±16, and 285±61nmol/mR, respectively,
prior to oil supplementation. After dietary
supplementation the content of these fatty
acids increased; LA + 105%, AA + 124% ,
EPA +146%, and DHA +146% as compared
with the values before the supple-
mentation. The increase was larger in EPA
Fig. 6. Changes in the mean levels of fatty
acids in serun phospholipids in pa-
tients with asthma after supple-
mentation with perilla seed oil.
(D) : before diet supplementation
and (00): 1 W, (!illl): 2W, (.):
3 W after the supplementation. 16:
o : palmitic acid, 18: 0 ; stearinic
acid, 18: 1 ; oleicacid, 18: 2n6 (LA) ;
linoleic acid, 20 : 4n6(AA) ; arach-
idonic acid, 20 : 5 n 3 (EPA);
eicosapentaenoic acid, 22: 6n3 (DHA) ;
docosahexaic acid.
and DHA than in AA and other fatty acids
(Fig. 6).
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Discussion
Bronchial allergen challenge induces imme-
diate asthmatic reaction (IAR) within 30 min
and late asthmatic reaction (LAR) which
occurs at 6 to 8 hours after the challnge.
The LAR, in which inflammatory cells such
as lymphocytes, neutrophils, eosinophils and
basophils migrate into allergic reaction sites
in the airways 1HO) , is closely associated with
bronchial hyperresponsiveness 21,22) .
Leukotrienes, one of the major chemical
mediators in asthma, play important roles in
the LAR. Any beneficial effects of n- 3 fatty
acids were not observed in many of patients
with asthma studied in relation to peak flow
rate, symptoms score, and need for bron-
chodilators 4). However, it has been found
that there was a reduction in the LAR in
subjects with dietary supplementation with
fish oil. Another report showed that subjects
taking MaxEPA had a blunting of the LAR
to allergen challengeS). Dry et al. also re-
ported that asthma patients taking fish oil
chronically appeared to have a statistically
significant improvement of pulmonary func-
tions 6). In patients with hayfever accompa-
nied with asthma, a significant reduction in
nasal symptoms during the pollen season, but
not in asthma symptoms, was observed by
dietary supplementation with fish oil 7) •
Leukotrienes are made in large amounts
during allergic reactions. Sulfid-peptide
leukotrienes of the 'five series' from EPA
have relatively similar properties to those of
the 'four series' from arachidonate23). There-
fore, it has been speculated that changing
from production of the usual • 4 -series' leu-
kotrienes to the '5 -series' from EPA might
not result in a large difference in allergic
reaction. LTB 4 is chemotactic and recruits
many inflammatory cells into allergic reac-
tion sites in the airways. LTB 4 stimulation
is reduced by n- 3 fatty acids24,25). Both LTB
4 from arachidonate and LTB 5 from EPA
have a similar biological activities, however,
the action of LTB 5 is very weak compared
to LTB 4.
In contrast, cyclooxygenase oroducts made
from EPA have different biological avtivities
from those from arachidonate. Thromboxane
A 3 does not stimulate piatelets in the way
that thromboxane A 2 does. LTB 5 and
thromboxane A 3 made from n- 3 fatty
acids are different in the degree and charac-
ter of biological activities from those of LT
B 4 and thromboxane A 2 from arach-
idonate.
A recent report has demonstrated that
supplementation with EPA decreases the
generation of LTB 4 and LTC 4 from
leucocytes26). However, clinical efficacy of
EPA on asthma was observed at only one
time point (2 months after the begining of
supplementation) during the 3 -month study.
In the present study, effects of a -linolen
ic acid enriched perilla seed oil on bronchial
asthma were examined. The results obtained
here revealed that dietary supplementation
with a -linolenic acid improves symptoms
and ventilatory function in patients with
asthma, and decreases the generation of LTB
4 and LTC 4 by leucocytes. Regarding com-
position of serum phospholipid fatty acids,
concentrations of EPA, DHA and AA tended
to increase after dietary supplementation
with a -linolenic acid. Further studies are
needed for detail analysis of a change in
composition of serm phospholipid fatty acids
by a -linolenic acid administration.
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気管支鳴息におけるエゴマ油と白血球のロイコト
リエンB4,C4合成
芦田耕三,御船尚志,光延文裕,保崎泰弘,
柘野浩史,横田 聡,谷崎勝朗,山本純子 1),
辻 孝夫2)
岡山大学医学部付属病院三朝分院内科, 2)医学部
第1内科,中国短期大学食物栄養科1)
近年,ロイコトリエンと遅発型気管支反応
(LAR)との密接な関連が注目されている｡本論
文では,アラキドン酸 (AA)代謝を通してロイ
コトリエン合成に関与すると推定される,αリノ
レン酸を多く含むェゴマ油による食事療法の塩床
効果を,気管支噂息を対象に検討した｡臨床症状
および換気機能は,2週間のエゴマ油投与で明ら
かな改善差傾向を示した｡CaionophoreA23187
刺激時の白血球のLTB4およびLTC4産生は,
エゴマ油投与により,投与前に比べ有意の減少を
示した (p<0.05)｡血中脂肪酸に関しては,イエ
イコサペンタエン酸 (EPA),ドコサヘキサエン
酸 (DHA)およびAA濃度は,エゴマ油投与に
より増加傾向を示し,同時にEPA/AA比も増加
する傾向が見られた｡以上の結果より,エゴマ油
による食事療法は,治療上有用であると考えられ
た｡
索引用語 :n-3系脂肪酸,気管支鴨息,アラキド
ン酸,LT王34,LTC4
